2004
Childhood maltreatment as a risk factor for adult cardiovascular disease and depression.
Batten SV, Aslan M, Maciejewski PK, Mazure CM. Childhood maltreatment as a risk factor for adult cardiovascular disease and depression. The Journal Of Clinical Psychiatry 2004, 65: 249-54. PMID: 15003081, DOI: 10.4088/jcp.v65n0217.Peer-Reviewed Original ResearchConceptsCardiovascular diseaseRisk factorsChildhood maltreatmentAdult depressionMultiple logistic regression modelAdult cardiovascular diseasePotent risk factorEffective clinical assessmentNational Comorbidity SurveySignificant increaseU.S. National Comorbidity SurveyLogistic regression modelsSex differencesCardiovascular eventsRepresentative sampleClinical assessmentLifetime depressionDiseaseAdult HealthPhysical outcomesWomenDepressionChildhood abuseMenDemographic factors
2001
Gender Differences in Referral to Cardiac Rehabilitation Programs after Revascularization
Caulin-Glaser T, Blum M, Schmeizl R, Prigerson H, Zaret B, Mazure C. Gender Differences in Referral to Cardiac Rehabilitation Programs after Revascularization. Journal Of Cardiopulmonary Rehabilitation And Prevention 2001, 21: 24-30. PMID: 11271654, DOI: 10.1097/00008483-200101000-00006.Peer-Reviewed Original ResearchConceptsCoronary revascularization proceduresCoronary bypass surgeryRevascularization proceduresSecondary preventionCR programPrevention instructionCardiac rehabilitation referralCases-observational studyInstruction of patientsCardiac rehabilitation programSecondary prevention strategiesBypass surgeryCardiac rehabilitationCoronary stentingRehabilitation referralPatient populationPhysician referralCardiovascular diseaseObservational studyRehabilitation programPrevention strategiesGender differencesHealthcare providersReferralDecreased likelihood
1998
Management of the Adverse Effects of Clozapine
Young CR, Bowers MB, Mazure CM. Management of the Adverse Effects of Clozapine. Schizophrenia Bulletin 1998, 24: 381-390. PMID: 9718630, DOI: 10.1093/oxfordjournals.schbul.a033333.Peer-Reviewed Original ResearchConceptsAdverse effectsElevated liver enzymesPercent of patientsSuccessful pharmacological managementPositive therapeutic outcomesHypothesized pathophysiologyPharmacological managementRefractory schizophreniaNeuromuscular effectsTraditional neurolepticsLiver enzymesPharmacological interventionsClozapineAffective disordersTherapeutic outcomesNeurological disordersMental disordersMaximum doseObsessive-compulsive symptomsWeight gainDisordersPatientsPathophysiologyNew hopeTreatment